• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

    1/10/24 8:02:59 AM ET
    $AEHR
    $AWIN
    $ELEV
    $GGE
    Electrical Products
    Industrials
    Aerospace
    Industrials
    Get the next $AEHR alert in real time by email

    Shares of Aehr Test Systems (NASDAQ:AEHR) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance.

    The company said revenue will likely be impacted by an anticipated delay in the timing of new orders from current and new customers.

    Aehr Test Systems shares dipped 15% to $18.99 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Exicure, Inc. (NASDAQ:XCUR) shares rose 35.5% to $0.84 in pre-market trading. Exicure was granted broad U.S. patent #11866700 for "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer's)."
    • iCoreConnect Inc. (NASDAQ:ICCT) shares rose 32.3% to $1.72 in pre-market trading. iCoreConnect announced strategic acquisition of Verifi Dental.
    • Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares jumped 15.8% to $7.40 in pre-market trading after surging more than 60% on Tuesday.
    • Microvast Holdings, Inc. (NASDAQ:MVST) shares gained 13.8% to $1.40 in pre-market trading after falling 5% on Tuesday.
    • SMART Global Holdings Inc. (NASDAQ:SGH) gained 10.7% to $20.45 in pre-market trading after the company posted better-than-expected earnings for its first quarter and announced approval of $75 million share repurchase authorization.
    • PriceSmart, Inc. (NASDAQ:PSMT) gained 10% to $80.20 in pre-market trading as the company reported better-than-expected earnings for its first quarter on Tuesday.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) surged 9.1% to $22.93 in pre-market trading. TG Therapeutics recently announced that it has entered into an agreement with Precision BioSciences to acquire a worldwide license to Precision's Azercabtagene Zapreleucel (azer-cel), an allogeneic CD19 CAR T cell therapy program for autoimmune diseases and all other non-oncology indications.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) shares climbed 8.5% to $0.91 in pre-market trading after falling around 7% on Tuesday.
    • Green Giant Inc. (NASDAQ:GGE) shares rose 7.6% to $0.0440 in pre-market trading after declining around 5% on Tuesday.
    • Intuitive Surgical, Inc. (NASDAQ:ISRG) gained 5.3% to $348.01 in pre-market trading. Intuitive Surgical said it sees preliminary revenue of $1.93 billion for the fourth quarter, versus market estimates of $1.87 billion.

    Losers

    • Roma Green Finance Limited (NASDAQ:ROMA) shares fell 29.3% to $2.05 in pre-market trading after dipping over 27% on Tuesday. Roma Green Finance announced pricing of $12.3 million public offering of 2,449,943 of shares at price of $4.00 per share.
    • HWH International Inc. (NASDAQ:HWH) shares fell 16.3% to $2.36 in pre-market trading after dipping 26% on Tuesday.
    • NexImmune, Inc. (NASDAQ:NEXI) shares fell 12.6% to $10.31 in pre-market trading after jumping over 55% on Tuesday.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) fell 10.2% to $0.2672 in pre-market trading after gaining 22% on Tuesday.
    • Elevation Oncology, Inc. (NASDAQ:ELEV) shares fell 8.1% to $1.81 in pre-market trading after gaining around 9% on Tuesday. Elevation Oncology recently said that it plans to provide an update from its ongoing Phase 1 trial of EO-3021 in mid-2024, with additional data expected in the first half of 2025.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) shares fell 7.4% to $0.1952 in pre-market trading after jumping 41% on Tuesday.
    • Wearable Devices Ltd. (NASDAQ:WLDS) fell 6.7% to $0.42 in pre-market trading.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares declined 6.5% to $0.1230 in pre-market trading. AERWINS Technologies recently entered into a letter of intent to form an entity with Helicopter Technology.
    • Sasol Limited (NYSE:SSL) shares fell 4.7% to $9.28 in pre-market trading.

     

    Now Read This: Citigroup Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

    Get the next $AEHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEHR
    $AWIN
    $ELEV
    $GGE

    CompanyDatePrice TargetRatingAnalyst
    Aehr Test Systems
    $AEHR
    4/8/2026$68.00Hold → Buy
    Craig Hallum
    Intuitive Surgical Inc.
    $ISRG
    3/11/2026$590.00Neutral → Buy
    Citigroup
    Sasol Ltd.
    $SSL
    3/5/2026Buy → Neutral
    UBS
    Aehr Test Systems
    $AEHR
    3/2/2026Mkt Perform → Outperform
    William Blair
    Sasol Ltd.
    $SSL
    2/9/2026Buy → Neutral
    Goldman
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Sasol Ltd.
    $SSL
    1/16/2026Neutral → Underweight
    Analyst
    Aehr Test Systems
    $AEHR
    12/17/2025$29.00Buy
    Lake Street
    More analyst ratings

    $AEHR
    $AWIN
    $ELEV
    $GGE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for UKONIQ

    Submission status for TG THERAPEUTICS INC's drug UKONIQ (ORIG-1) with active ingredient UMBRALISIB TOSYLATE has changed to 'Approval' on 02/05/2021. Application Category: NDA, Application Number: 213176, Application Classification: Type 1 - New Molecular Entity

    2/9/21 12:05:59 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHR
    $AWIN
    $ELEV
    $GGE
    SEC Filings

    View All

    SEC Form 6-K filed by Wearable Devices Ltd.

    6-K - Wearable Devices Ltd. (0001887673) (Filer)

    4/24/26 9:16:51 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    SEC Form 144 filed by PriceSmart Inc.

    144 - PRICESMART INC (0001041803) (Subject)

    4/23/26 4:10:28 PM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 6-K filed by Sasol Ltd.

    6-K - SASOL LTD (0000314590) (Filer)

    4/23/26 9:00:55 AM ET
    $SSL
    Oil & Gas Production
    Energy

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aehr Test Systems upgraded by Craig Hallum with a new price target

    Craig Hallum upgraded Aehr Test Systems from Hold to Buy and set a new price target of $68.00

    4/8/26 8:22:11 AM ET
    $AEHR
    Electrical Products
    Industrials

    Intuitive Surgical upgraded by Citigroup with a new price target

    Citigroup upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $590.00

    3/11/26 8:28:54 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Sasol downgraded by UBS

    UBS downgraded Sasol from Buy to Neutral

    3/5/26 10:20:38 AM ET
    $SSL
    Oil & Gas Production
    Energy

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wearable Devices Receives U.S. Patent Notice of Allowance for Biometric User Authentication in Gesture and Voice-Controlled Interface Device

    New continuation patent protects the ability to authenticate users from their unique biological signals, unlocking secure payments, user detection, and authorized actions Yokneam Illit, Israel, April 24, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new continuation patent in its foundational patent family titled "Gesture and Voice-Controlled Interface Device." This continuation patent application, for wh

    4/24/26 9:15:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    BUSINESS PERFORMANCE METRICS FOR THE NINE MONTHS ENDED 31 MARCH 2026 AND REVISED GUIDANCE

    JOHANNESBURG, April 23, 2026 /PRNewswire/ -- Sasol has published its business performance metrics for the nine months ended 31 March 2026 on the Company´s website at www.sasol.com, under the Investor Centre section: https://www.sasol.com/investor-centre/financial-results. The importance of domestic supply of both energy and chemical products and Sasol's role in delivering it was reinforced during this quarter following the conflict in the Middle East and the associated closure of the Strait of Hormuz.Our response has been focused on sustaining uninterrupted operations and leveraging our integrated value chain to ensure consistent supply of products to our customers while maintaining discipli

    4/23/26 2:11:00 AM ET
    $SSL
    Oil & Gas Production
    Energy

    Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

    CHICAGO, April 22, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (NASDAQ:XCUR) today announced that it has entered into a co-development agreement with Adbiotech Co., Ltd. (KOSDAQ: 179530), a Korea-based biotechnology company, to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. The collaboration will focus on evaluating combination strategies involving Burixafor (GPC-100) in indications including sickle cell disease (SCD), acute myeloid leukemia (AML), and solid tumors. Under the agreement, Adbiotech will conduct in vivo studies and support preclinical validation and translational research, while Exicure will provide Burixafor and lead clinical and r

    4/22/26 7:54:21 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Schonfeld Strategic Advisors Llc sold $79,589 worth of shares (41,400 units at $1.92) and bought $372,143 worth of shares (146,800 units at $2.54) (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    4/28/25 6:12:27 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Large owner Hitron Systems Inc. bought $8,700,000 worth of shares (2,900,000 units at $3.00), increasing direct ownership by 669% to 3,333,333 units (SEC Form 4)

    4 - EXICURE, INC. (0001698530) (Issuer)

    3/26/25 5:41:19 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Chang Nancy T bought $499,979 worth of shares (7,644,932 units at $0.07) (SEC Form 4)

    4 - Galera Therapeutics, Inc. (0001563577) (Issuer)

    1/2/25 4:12:36 PM ET
    $GRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Price Robert E sold $3,213,884 worth of shares (20,000 units at $160.69) (SEC Form 4)

    4 - PRICESMART INC (0001041803) (Issuer)

    4/24/26 2:34:39 PM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 4 filed by Posedel Rhea J

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    4/22/26 5:29:56 PM ET
    $AEHR
    Electrical Products
    Industrials

    SEC Form 4 filed by Sporck Alistair N

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    4/22/26 5:22:49 PM ET
    $AEHR
    Electrical Products
    Industrials

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Leadership Updates

    Live Leadership Updates

    View All

    Wearable Devices Strengthens AI Advisory Board with Former Google and Qualcomm Executives to Accelerate ai6 Labs' Vision

    Yokneam Illit, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced a significant expansion of its AI expert advisory board. This strategic enhancement strengthens the Company's commitment to advancing neural AI innovation through ai6 Labs. The recently launched ai6 Labs is focused on advancing the Company's revolutionary neural AI technology powered by non-invasive electromyography (EMG) technology and the Mudra platform, supporting a closed-loop ecosystem designed to seamlessly connect hu

    3/16/26 8:45:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    CHANGES TO SASOL LIMITED BOARD OF DIRECTORS

    JOHANNESBURG, Jan. 21, 2026 /PRNewswire/ -- In compliance with para 3.59 of the JSE Listings Requirements and para 6.39 of the JSE Debt and Specialist Securities Listings Requirements, Sasol is pleased to announce the appointment of Mr Rhidwaan Gasant as independent non-executive director with effect from 1 February 2026. Mr Gasant satisfies the independence requirements for directors under applicable requirements in South Africa and the United States. Mr Gasant is a Chartered Accountant and served as a senior audit manager at KPMG before joining Mobil Oil Southern Africa. He was the former Financial Director of Engen Limited and Chief Executive Officer of Energy Africa Limited. Mr Gasant h

    1/21/26 10:01:00 AM ET
    $SSL
    Oil & Gas Production
    Energy

    Intel Appoints Dr. Craig H. Barratt to Board of Directors

    Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute

    11/10/25 6:21:00 PM ET
    $ALAB
    $INTC
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Financials

    Live finance-specific insights

    View All

    Intuitive Announces First Quarter Earnings

    SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2026. Q1 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 17% compared with the first quarter of 2025. Da Vinci procedures grew approximately 16%, and Ion procedures grew approximately 39%.The Company placed 431 da Vinci surgical systems, compared with 367 in the first quarter of 2025. The first quarter 2026 da Vinci surgical system placements included 232 da Vinci 5 systems, compared with 147 in the fi

    4/21/26 4:38:28 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    PRICESMART ANNOUNCES FISCAL 2026 SECOND QUARTER OPERATING RESULTS AND PLANS FOR EIGHTH CLUB IN GUATEMALA

    NET MERCHANDISE SALES GREW 9.9%COMPARABLE NET MERCHANDISE SALES INCREASED 7.6% $1.62 EARNINGS PER DILUTED SHARESAN DIEGO, April 8, 2026 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the "Company") (NASDAQ:PSMT), operator of 56 warehouse clubs in 12 countries and one U.S. territory, today announced results for the fiscal second quarter of 2026, which ended on February 28, 2026. Second Quarter Financial ResultsTotal revenues for the second quarter of fiscal year 2026 increased 9.7% to $1.50 billion compared to $1.36 billion in the comparable period of the prior year. For the s

    4/8/26 4:01:00 PM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Exicure, Inc. Reports Full Year 2025 Financial Results

    REDWOOD CITY, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (NASDAQ:XCUR, the "Company")) releases the following financial results for the year ended December 31, 2025. 2025 Financial Results Cash Position: Cash and cash equivalents were $3.7 million as of December 31, 2025, compared to $12.5 million as of December 31, 2024. Our current liquidity may not be sufficient to fund operations for the next 12 months. Additional financing will be required to support ongoing operations, continue the exploration of strategic alternatives, and pursue any alternatives that we identify. Research and Development (R&D) Expense: Research and development expenses were $3.3 million for the ye

    3/25/26 4:18:31 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHR
    $AWIN
    $ELEV
    $GGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13D filed by Exicure Inc.

    SC 13D - EXICURE, INC. (0001698530) (Subject)

    11/29/24 5:51:28 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care